Cargando…
Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin
Prevalence of diabetes mellitus is inc6reasing, with a burden of 382 million patients worldwide at present (more than the entire US population). The International Diabetes Federation anticipates an increase up to 592 million patients by 2035. Another major problem arises from the fact that just 50%...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259905/ https://www.ncbi.nlm.nih.gov/pubmed/25365416 http://dx.doi.org/10.1038/nutd.2014.40 |